Best Pharmaceuticals Stocks in India — 2026 Rankings
14 companies AI-ranked by earnings call analysis. 1 with strong growth signals this quarter.
Total Companies
14
Rank 1 (40%+ growth)
1
Rank 2 (20-40% growth)
0
Active Capex
14
Sector Leaderboard
| # | Company | Market Cap | Revenue | Margin | Capex | Fundraise |
|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Company | 9.5L Cr | Rank 1 | Rank 3 | Yes | — |
| 2 | Teva Pharmaceutical Industries Limited | 40.2K Cr | Rank 4 | Rank 1 | Yes | — |
| 3 | Royalty Pharma plc | 31.4K Cr | Rank 3 | Rank 3 | Yes | — |
| #4 | AstraZeneca PLC | 2.9L Cr | Rank 3 | Rank 3 | Yes | — |
| #5 | Pfizer Inc. | 1.5L Cr | Rank 3 | Rank 3 | Yes | — |
| #6 | GSK plc | 1.0L Cr | Rank 3 | Rank 3 | Yes | — |
| #7 | Johnson & Johnson | 5.5L Cr | Rank 3 | Rank 4 | Yes | — |
| #8 | Novartis AG | 2.9L Cr | Rank 4 | Rank 3 | Yes | — |
| #9 | Sanofi | 1.1L Cr | Rank 4 | Rank 3 | Yes | — |
| #10 | Takeda Pharmaceutical Company Limited | 50.1K Cr | Rank 4 | Rank 3 | Yes | — |
| #11 | Haleon plc | 41.0K Cr | Rank 4 | Rank 3 | Yes | — |
| #12 | Zoetis Inc. | 32.8K Cr | Rank 4 | Rank 3 | Yes | — |
| #13 | Viatris Inc. | 18.8K Cr | Rank 4 | Rank 3 | Yes | — |
| #14 | Novo Nordisk A/S | 2.0L Cr | Rank 4 | Rank 4 | Yes | — |
Frequently Asked Questions
Which are the best Pharmaceuticals stocks in India?
Based on AI analysis of the latest earnings calls, the top Pharmaceuticals stocks include Eli Lilly and Company, Teva Pharmaceutical Industries Limited, Royalty Pharma plc, AstraZeneca PLC, Pfizer Inc.. These companies are ranked by revenue growth, margin strength, and capex activity.
How is the Pharmaceuticals sector performing in 2026?
The Pharmaceuticals sector currently has 14 tracked companies. 1 companies show strong revenue growth above 40%, and 14 companies have active capital expenditure programs, indicating expansion and investment in the sector.
How many Pharmaceuticals companies have high growth in 2026?
Out of 14 Pharmaceuticals companies tracked, 1 are classified as Rank 1 with over 40% revenue growth, and 0 are Rank 2 with 20-40% growth, based on AI-powered earnings call analysis.